Announced
Completed
Financials
Tags
Completed
Acquisition
Venture Capital
Friendly
Biotechnology
Minority
Single Bidder
Private Equity
clinical-stage biotech
Private
United States
Cross Border
Synopsis
Flagship Pioneering led a $189m Series B round in Repertoire Immune Medicines, a clinical-stage biotech company, with participation from Softbank Vision Fund 2, PSP Investments, Alaska Permanent Fund and Invus. Proceeds from this financing will support further expansion of the company’s proprietary DECODE discovery platform, accelerate its clinical and preclinical pipeline, expand Repertoire’s team, and enhance its manufacturing capabilities.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.